Modelling intervention effects after cancer relapses

This article addresses the problem of incorporating information regarding the effects of treatments or interventions into models for repeated cancer relapses. In contrast to many existing models, our approach permits the impact of interventions to differ after each relapse. We adopt the general model for recurrent events proposed by Peña and Hollander, in which the effect of interventions is represented by an effective age process acting on the baseline hazard rate function. To accommodate the situation of cancer relapse, we propose an effective age function that encodes three possible therapeutic responses: complete remission, partial remission, and null response. The proposed model also incorporates the effect of covariates, the impact of previous relapses, and heterogeneity among individuals. We use our model to analyse the times to relapse for 63 patients with a particular subtype of indolent lymphoma and compare the results to those obtained using existing methods.

[1]  Myles Hollander,et al.  Models for Recurrent Events in Reliability and Survival Analysis , 2004 .

[2]  L. Holmberg,et al.  Local recurrence in the breast after conservative surgery--a study of prognosis and prognostic factors in 391 women. , 2002, European journal of cancer.

[3]  A. V. Peterson,et al.  On the regression analysis of multivariate failure time data , 1981 .

[4]  R. Gill,et al.  Cox's regression model for counting processes: a large sample study : (preprint) , 1982 .

[5]  Francisco J. Samaniego,et al.  Estimating the Reliability of Systems Subject to Imperfect Repair , 1989 .

[6]  David Oakes,et al.  Frailty Models For Multiple Event Times , 1992 .

[7]  J. Sethuraman,et al.  Nonparametric estimation for a general repair model , 1997 .

[8]  Allen R. Chen,et al.  Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  A. López-Guillermo,et al.  Survival after progression in patients with follicular lymphoma: analysis of prognostic factors. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  P. Mclaughlin Profiling: "Editorial on 'Survival after progression in patients with follicular lymphoma: analysis of prognostic factors'", by S. Montoto et al. (Ann Oncol 2002; 13: 523-30). , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  P J Kelly,et al.  Survival analysis for recurrent event data: an application to childhood infectious diseases. , 2000, Statistics in medicine.

[12]  W. Bezwoda,et al.  Prolonged survival in follicular non Hodgkins lymphoma is predicted by achievement of complete remission with initial treatment: results of a long-term study with multivariate analysis of prognostic factors. , 1996, Leukemia & lymphoma.

[13]  B. Cheuvart,et al.  A nonparametric model for multiple recurrences , 1988 .

[14]  T M Therneau,et al.  rhDNase as an example of recurrent event analysis. , 1997, Statistics in medicine.

[15]  Myles Hollander,et al.  Nonparametric Methods for Imperfect Repair Models , 1992 .

[16]  T. Lister,et al.  Management of follicular lymphoma , 1991, Current opinion in oncology.

[17]  R. Broll,et al.  p53 and Bcl-2 as significant predictors of recurrence and survival in rectal cancer. , 2000, European journal of cancer.

[18]  W. Velasquez,et al.  Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  T. Estrach,et al.  Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases. , 2002, The British journal of dermatology.

[20]  F. Angrilli,et al.  Bleomycin, Epidoxorubicin, Cyclophosphamide, Vincristine and Prednisone (BACOP) in Patients with Follicular Non-Hodgkin's Lymphoma: Results of a Prospective, Multicenter Study of the Gruppo Italiano Per Lo Studio Dei Linfomi (GISL) , 2002, Leukemia & lymphoma.

[21]  M. Oken,et al.  Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantation. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Masaaki Kijima,et al.  Periodical replacement problem without assuming minimal repair , 1988 .

[23]  T. Santner,et al.  An analysis of comparative carcinogenesis experiments based on multiple times to tumor. , 1980, Biometrics.

[24]  A. López-Guillermo,et al.  Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  P. Grambsch,et al.  Modeling Survival Data: Extending the Cox Model , 2000 .

[26]  J. Armitage,et al.  Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  L. J. Wei,et al.  Regression analysis of multivariate incomplete failure time data by modeling marginal distributions , 1989 .

[28]  T. H. Savits,et al.  Age Dependent Minimal Repair. , 1985 .

[29]  M. Kijima SOME RESULTS FOR REPAIRABLE SYSTEMS WITH GENERAL REPAIR , 1989 .

[30]  W. Velasquez,et al.  Therapy of relapsed or refractory low-grade follicular lymphomas: factors associated with complete remission, survival and time to treatment failure. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.